Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > 2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide for Sale > 2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide
2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide buy - large image1
2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide buy - image1

2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide

4 Inquiries

Unit Price: Get Latest Price
CAS No.:

1225208-44-5

Grade:

Chemical Grade

Packaging:

bottle

Price valid (until):

2024-08-02

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Boiling point  649.6±55.0 °C(Predicted)
    density  1.216±0.06 g/cm3(Predicted)
    pka 13.40±0.46(Predicted)

    Basic Info
    Product Name:

    2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide

    CAS No.:

    1225208-44-5

    Molecular Formula:

    C29H33ClN2O5

    Exact Mass:

    524.208

    Characteristics
    PSA:

    69.26

    XLogP3:

    5.6696

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Avibactam Sodium,Blonanserin,Relebactam,Tofacitinib

    Location:

    2F Building 10, Zhuhai International Health Port, 628 Airport West Road, Sanzao Town, Jinwan District, Zhuhai, Guangdong, China 519090

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    101-200

    Year of Establishment:

    2012

    Certifications:

    CERTIFICATE OF REGISTRATION

    NewRoute Pharmaceutical Technology Co., Ltd

    NewRoute Pharma  located in Zhuhai, Guangdon Province, is an innovation-oriented enterprise who engages in R&D, production and sales of API, intermediates, formulations and impurity standards.

    Since its establishment in 2012 , the company has maintained a leading momentum in the field of new drug development . Specialized in new drug technology development and achievement transfer , our company is capable of providing other enterprises with various new drug R&D , production and supporting services , which is the reason for many pharmaceutical enterprises to establish strategic cooperation with us .

  • Inquiry History
    4 Inquiries
    Country Product Purchase Quantity Date Posted
    Italy

    2-chloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide

    25 KG Oct 24, 2023
    Italy

    1-(2-Aminoethyl)pyrrolidine

    25 KG Oct 24, 2023
    Italy

    2-chloro-3,4-bis[(4-methoxyphenyl)methoxy]Benzoic acid

    25 KG Oct 24, 2023
    Italy

    2-chloro-3,4-dihydroxybenzoicacid

    25 KG Oct 24, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.